Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Tags
-
Symposium on mRNA 2025 Summary Infographic
Summary Infographic: Symposium on mRNA 2025 -
Symposium on mRNA 2025 Scientific Program
Scientific Program: Symposium on mRNA 2025 -
Metaphorical mRNA: The Current & Future Shape(s) of the mRNA Therapeutics Industry
Speaker Presentation: Symposium on mRNA 2025Welch Anna Rose, Advancing RNA, 2025 -
mRNA Vaccines an EU Regulator‘s Perspective
Speaker Presentation: Symposium on mRNA 2025Schlick Petra, AGES - Austria, 2025 -
Quality by Design for
mRNA Products
Speaker Presentation: Symposium on mRNA 2025O'Neill Julia, Direxa Consulting, 2025 -
Development of mRNA-LNP Manufacturing Process Platform
Speaker Presentation: Symposium on mRNA 2025Luthra Sumit, Sanofi, 2025 -
Establishing Quality Benchmarks: Platform
Technology Approach to mRNA Product Quality
Speaker Presentation: Symposium on mRNA 2025Kattel Sarita, US Pharmacopeia, 2025 -
Early Regulatory Considerations for RNA Therapies for Rare Diseases
Speaker Presentation: Symposium on mRNA 2025Hagan Julie, Korro Bio, 2025 -
Analytical Comparability of mRNA Vaccines: Supporting the
Global Rollout of Comirnaty® and Streamlining the Strategy for
the mRNA Vaccine Pipeline
Speaker Presentation: Symposium on mRNA 2025Eschmann Neil, Pfizer, Inc., 2025 -
A Trailblazing Digital
Approach Coupled with
PAT-Enabled Rapid
Manufacturing from MIT
and ReciBiopharm (Case
Study No. 01 xRNA)
Speaker Presentation: Symposium on mRNA 2025Cowley Aaron, ReciBioPharm, 2025 -
A to Z of IVE: From Single Antigen to Multiplex Flow Cytometry and LC-MS/MS
Speaker Presentation: Symposium on mRNA 2025Byrne Emilia, Pfizer, Inc., 2025